USPTO serial 75544637
TRINOVIN
Reviewed by CopyMark Law Group
Reg. 2947025Status 710
- Filing date
- Status date
- Registration date
- May 10, 2005
- Examiner
- LEIPZIG, MARC J
- Law office
- TMO LAW OFFICE 115
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with TRINOVIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New South Wales, 2113, AU
New South Wales, 2113, AU
New South Wales, 2113, AU
PHARM-A-CARE (AUSTRALIA) PTY LIMITED
NORTH SYDNEY, NEW SOUTH WALES, AU
Other trademarks owned by PHARM-A-CARE (AUSTRALIA) PTY LIMITED
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | non-prescription pharmaceutical preparations containing phytoestrogens, their metabolites, and/or glucan for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular system, including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damages, cognitive function, arthritis, and cataracts; homeopathic preparations and herbal extracts derived from phytoestrogen-containing plants including their metabolites, for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular systems including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damage, cognitive function, arthritis and cataracts specifically excluding prescription and non-prescription pharmaceutical preparations for the treatment, relief, or alleviation of coughs, colds, allergy symptoms, and diseases of the larynx, pharynx, nose, and lungs, and antihistamine and decongestant pharmaceutical preparations | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Novogen Research Pty Limited
- Other trademarks owned by Novogen Research Pty Limited
- Other trademarks owned by Novogen Research Pty Limited
- Other trademarks owned by PHARM-A-CARE (AUSTRALIA) PTY LIMITED
- Other trademarks in Class 005
- Similar marks named TRINOVIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2015 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 9, 2011 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 7, 2011 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 7, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 9, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 10, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2004 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 16, 2004 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 16, 2004 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 16, 2004 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 20, 2001 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 25, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 9, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 8, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 16, 2000 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2000 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Mar 1, 2000 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 16, 2000 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2000 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Jan 18, 2000 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 21, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 1999 | DOCK | ASSIGNED TO EXAMINER | — |